Go to
JCI Insight
About
Editors
Consulting Editors
For authors
Publication ethics
Publication alerts by email
Advertising
Job board
Contact
100th anniversary
Current issue
Past issues
By specialty
COVID-19
Cardiology
Gastroenterology
Immunology
Metabolism
Nephrology
Neuroscience
Oncology
Pulmonology
Vascular biology
All ...
Videos
Conversations with Giants in Medicine
Author's Takes
Reviews
Reviews
View all reviews ...
Review Series
Vascular Malformations (Apr 2024)
Lung inflammatory injury and tissue repair (Jul 2023)
Immune Environment in Glioblastoma (Feb 2023)
Korsmeyer Award 25th Anniversary Collection (Jan 2023)
Aging (Jul 2022)
Next-Generation Sequencing in Medicine (Jun 2022)
New Therapeutic Targets in Cardiovascular Diseases (Mar 2022)
View all review series ...
Viewpoint
Collections
In-Press Preview
Clinical Medicine
Research Letters
Letters to the Editor
Editorials
Commentaries
Reviews
Viewpoints
Top read articles
Clinical Medicine
Does treating with anti–PD-1 to improve glomerular health come without a cost?
Kenar D. Jhaveri, … , Abhijat Kitchlu, Ala Abudayyeh
Kenar D. Jhaveri, … , Abhijat Kitchlu, Ala Abudayyeh
Published November 15, 2022
Citation Information:
J Clin Invest.
2022;
132(22)
:e164747.
https://doi.org/10.1172/JCI164747
.
View:
Text
|
PDF
Letter to the Editor
Nephrology
Does treating with anti–PD-1 to improve glomerular health come without a cost?
Text
PDF
Abstract
Authors
Kenar D. Jhaveri, Abhijat Kitchlu, Ala Abudayyeh
×
Full Text PDF |
Download
(1.38 MB)